- Home
- LAES vs RCKT Comparison
LAES vs RCKT Comparison
Compare LAES & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- RCKT
- Stock Information
- Founded
- LAES 2022
- RCKT 1999
- Country
- LAES Switzerland
- RCKT United States
- Employees
- LAES N/A
- RCKT N/A
- Industry
- LAES Semiconductors
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- RCKT Health Care
- Exchange
- LAES Nasdaq
- RCKT Nasdaq
- Market Cap
- LAES 304.2M
- RCKT 326.4M
- IPO Year
- LAES N/A
- RCKT N/A
- Fundamental
- Price
- LAES $3.90
- RCKT $2.65
- Analyst Decision
- LAES Strong Buy
- RCKT Buy
- Analyst Count
- LAES 1
- RCKT 13
- Target Price
- LAES $6.00
- RCKT $18.50
- AVG Volume (30 Days)
- LAES 11.7M
- RCKT 6.0M
- Earning Date
- LAES 07-07-2025
- RCKT 08-04-2025
- Dividend Yield
- LAES N/A
- RCKT N/A
- EPS Growth
- LAES N/A
- RCKT N/A
- EPS
- LAES N/A
- RCKT N/A
- Revenue
- LAES $10,981,000.00
- RCKT N/A
- Revenue This Year
- LAES N/A
- RCKT N/A
- Revenue Next Year
- LAES N/A
- RCKT N/A
- P/E Ratio
- LAES N/A
- RCKT N/A
- Revenue Growth
- LAES N/A
- RCKT N/A
- 52 Week Low
- LAES $0.29
- RCKT $2.19
- 52 Week High
- LAES $11.00
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- LAES 56.54
- RCKT 33.04
- Support Level
- LAES $3.43
- RCKT $2.56
- Resistance Level
- LAES $4.24
- RCKT $2.84
- Average True Range (ATR)
- LAES 0.34
- RCKT 0.25
- MACD
- LAES -0.04
- RCKT 0.11
- Stochastic Oscillator
- LAES 53.62
- RCKT 11.61
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.